Published in Int J Hepatol on October 29, 2011
Hepatic artery embolization for neuroendocrine tumors: postprocedural management and complications. Oncologist (2012) 0.82
MRI-guided laser ablation of neuroendocrine tumor hepatic metastases. Acta Radiol Short Rep (2014) 0.79
An overview of the surgical management of hepatic neuroendocrine metastases. Indian J Surg Oncol (2012) 0.75
The Treatment of Liver Metastases in Patients with Neuroendocrine Tumors in 2012. ISRN Hepatol (2013) 0.75
Indication for liver transplantation in young patients with small intestinal NETs is rare? World J Surg (2014) 0.75
One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol (2008) 15.05
Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med (2011) 11.93
Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med (2011) 11.55
Mechanisms of tissue injury in cryosurgery. Cryobiology (1998) 3.24
Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg (2005) 3.02
Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol (2008) 2.97
Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg (2007) 2.96
Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg (2003) 2.88
Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg (2000) 2.60
Karnofsky memorial lecture. An odyssey in the land of small tumors. J Clin Oncol (1987) 2.12
Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience. Cancer J (2003) 2.02
Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol (2009) 1.97
Radiofrequency ablation of malignant liver tumors. Oncologist (2001) 1.97
Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics (2005) 1.85
Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients. Am J Clin Oncol (2008) 1.84
Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg (1998) 1.83
Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg (1995) 1.82
Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database. Arch Surg (2011) 1.78
Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms. J Vasc Interv Radiol (1999) 1.75
Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases. Cancer (2008) 1.67
Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer (2005) 1.67
Hepatic surgery for metastases from neuroendocrine tumors. Surg Oncol Clin N Am (2003) 1.48
Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival. Surgery (2007) 1.48
Hepatic artery chemoinfusion with chemoembolization for neuroendocrine cancer with progressive hepatic metastases despite octreotide therapy. Surgery (2008) 1.46
Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report. Am J Transplant (2008) 1.38
Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis. Ann Surg Oncol (2011) 1.31
Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation (2002) 1.27
Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors. Cancer Control (2006) 1.27
Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors. Ann Surg Oncol (2006) 1.23
Metastatic neuroendocrine hepatic tumors: resection improves survival. Arch Surg (2006) 1.22
The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med (1994) 1.22
Efficacy and safety of microwave ablation for primary and secondary liver malignancies: a systematic review. Eur J Gastroenterol Hepatol (2009) 1.21
Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. J Clin Oncol (2005) 1.18
Result of liver resection as treatment for metastases from noncolorectal cancer. J Surg Oncol (2000) 1.18
Long-term survival after surgical management of neuroendocrine hepatic metastases. HPB (Oxford) (2010) 1.17
Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors. Cancer (1998) 1.17
Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract. Q J Nucl Med (2000) 1.14
Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET. J Nucl Med (2004) 1.12
Hepatic ablation using bipolar radiofrequency electrocautery. Acad Radiol (1996) 1.10
Highly aggressive policy of hepatic resections for neuroendocrine liver metastases. Hepatogastroenterology (2000) 1.05
Neuroendocrine metastases of the liver. World J Surg (1995) 1.05
Laparoscopic radiofrequency thermal ablation of neuroendocrine hepatic metastases: long-term follow-up. Surgery (2010) 1.05
Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study. Surgery (2003) 1.05
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: somatostatin receptor imaging with (111)In-pentetreotide. Neuroendocrinology (2009) 1.04
Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques. Cardiovasc Intervent Radiol (2005) 1.03
Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres. Cardiovasc Intervent Radiol (2011) 1.01
A review of systemic and liver-directed therapies for metastatic neuroendocrine tumors of the gastroenteropancreatic tract. Cancer Control (2011) 1.00
New applications of ultrasonography: interventional ultrasound. Eur J Radiol (1998) 0.97
Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors? J Nucl Med (2006) 0.96
Liver resection versus other treatments for neuroendocrine tumours in patients with resectable liver metastases. Cochrane Database Syst Rev (2009) 0.95
Thermal ablative therapies for secondary hepatic malignancies. Cancer J (2010) 0.95
Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Digestion (1994) 0.94
Progression and survival results after radical hepatic metastasectomy of indolent advanced neuroendocrine neoplasms (NENs) supports an aggressive surgical approach. Surgery (2010) 0.94
Hepatic artery chemoembolization for the treatment of liver metastases from neuroendocrine tumors: a long-term follow-up in 123 patients. Med Oncol (2010) 0.90
Hepatic surgery for metastatic gastrointestinal neuroendocrine tumors. Adv Exp Med Biol (2006) 0.90
Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors. AJR Am J Roentgenol (1998) 0.90
Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization. J Vasc Interv Radiol (2008) 0.90
Liver metastases: results of percutaneous ethanol injection in 14 patients. Radiology (1991) 0.89
Liver transplantation for hepatic metastases of neuroendocrine pancreatic tumors: a survival-based analysis. Transplantation (2011) 0.89
Peritoneal carcinomatosis in patients with digestive endocrine tumors. Cancer (1996) 0.89
Curable metastatic colorectal cancer. Curr Oncol Rep (2011) 0.88
Natural history of liver metastasis of gastroenteropancreatic neuroendocrine tumors: place for chemoembolization. World J Surg (2001) 0.87
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: echocardiography. Neuroendocrinology (2009) 0.87
Addition of octreotide functional imaging to cross-sectional computed tomography or magnetic resonance imaging for the detection of neuroendocrine tumors: added value or an anachronism? J Clin Oncol (2010) 0.87
Revisiting C.G. Moertel's land of small tumors. J Clin Oncol (2008) 0.86
Reduction of arteriohepatovenous shunting by temporary balloon occlusion in patients undergoing radioembolization. J Vasc Interv Radiol (2007) 0.86
Role of hepatic resection for patients with carcinoid heart disease. Mayo Clin Proc (2008) 0.86
Percutaneous alcohol ablation for liver metastasis. Semin Oncol (2002) 0.85
Cryotherapy for neuroendocrine liver metastases. Semin Surg Oncol (1998) 0.85
Role of interventional radiology in the treatment of patients with neuroendocrine metastases in the liver. J Natl Compr Canc Netw (2009) 0.85
ENETS consensus guidelines for the management of peritoneal carcinomatosis from neuroendocrine tumors. Neuroendocrinology (2010) 0.85
Ki-67 index, tumor differentiation, and extent of liver involvement are independent prognostic factors in patients with liver metastases of digestive endocrine carcinomas. Endocr Relat Cancer (2010) 0.84
Ultrasound-guided percutaneous alcohol injection of small liver metastases. Results in 40 patients. Cancer (1994) 0.82
Optimizing the surgical effort in patients with advanced neuroendocrine neoplasm hepatic metastases: a critical analysis of 40 patients treated by hepatic resection and cryoablation. Am J Clin Oncol (2012) 0.82
Integrating radioembolization into the treatment paradigm for metastatic neuroendocrine tumors in the liver. Am J Clin Oncol (2012) 0.82
Liver-specific therapies for metastases of neuroendocrine pancreatic tumors. World J Hepatol (2010) 0.81
Cryosurgical palliation of metastatic neuroendocrine tumors resistant to conventional therapy. Surgery (1997) 0.80
Multimodality treatment of neuroendocrine liver metastases. Surgery (2011) 0.80
Cryotherapy of metastatic carcinoid tumors. Abdom Imaging (1998) 0.79
Carcinoid syndrome. BMJ (2010) 0.78
Cell death along single microfluidic channel after freeze-thaw treatments. Biomicrofluidics (2010) 0.78
Proteolytic events in cryonecrotic cell death: Proteolytic activation of endonuclease P23. Cryobiology (2010) 0.77
Radiofrequency ablation of unresectable liver tumours. Hosp Med (2003) 0.76
Radiofrequency thermal ablation of metastatic neuroendocrine tumors in the liver. Curr Treat Options Oncol (2007) 0.75
Adjuvant chemotherapy in colon cancer: ageism or appropriate care? J Clin Oncol (2011) 0.76